| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | RIOT | United States | $15.26 | $637,162,000.00 | Strong Buy | 13 | N/A |
#2 | XPRO | United States | $14.01 | $1,661,811,000.00 | Buy | 4 | 2013 |
#3 | MARA | United States | $11.46 | $919,173,000.00 | Buy | 14 | N/A |
#4 | CWK | United States | $15.30 | $10,003,900,000.00 | Buy | 8 | 2018 |
#5 | ENLT | Israel | $38.81 | $457,756,000.00 | Buy | 6 | 2023 |
#6 | CWEN | United States | $32.43 | $1,375,000,000.00 | Strong Buy | 8 | 2013 |
#7 | AMX | Mexico | $21.30 | $51,012,503,011.00 | Buy | 6 | 2001 |
#8 | CTRE | United States | $36.20 | $428,478,000.00 | Buy | 6 | N/A |
#9 | TME | China | $18.21 | $4,455,416,345.00 | Strong Buy | 5 | 2018 |
#10 | BZ | China | $19.91 | $1,125,491,208.00 | Strong Buy | 4 | 2021 |
#11 | FE | United States | $44.19 | $14,283,000,000.00 | Buy | 14 | N/A |
#12 | DOCS | United States | $43.94 | $621,329,000.00 | Buy | 21 | 2021 |
#13 | TTD | United States | $36.60 | $2,790,505,000.00 | Buy | 35 | 2016 |
#14 | DX | United States | $13.54 | $230,447,000.00 | Buy | 4 | N/A |
#15 | PPL | United States | $33.97 | $8,979,000,000.00 | Buy | 9 | N/A |
#16 | BKR | United States | $46.79 | $27,711,000,000.00 | Strong Buy | 18 | N/A |
#17 | OGE | United States | $42.93 | $3,294,800,000.00 | Buy | 9 | N/A |
#18 | CGNX | United States | $35.54 | $971,705,000.00 | Buy | 12 | 1989 |
#19 | TIMB | Brazil | $21.54 | $4,941,546,695.00 | Buy | 4 | 1998 |
#20 | DINO | United States | $49.34 | $26,905,000,000.00 | Buy | 11 | N/A |
#21 | STVN | Italy | $20.88 | $1,373,219,524.00 | Buy | 4 | 2021 |
#22 | AMRC | United States | $30.04 | $1,883,767,000.00 | Buy | 9 | 2010 |
#23 | NI | United States | $41.39 | $6,327,100,000.00 | Buy | 9 | N/A |
#24 | VIV | Brazil | $12.30 | $10,989,199,704.00 | Buy | 4 | 1998 |
#25 | CNP | United States | $37.78 | $9,114,000,000.00 | Buy | 12 | N/A |
#26 | NAMS | Netherlands | $37.15 | $35,243,000.00 | Strong Buy | 10 | N/A |
#27 | WULF | United States | $14.27 | $167,604,000.00 | Strong Buy | 12 | 1995 |
#28 | BILI | China | $24.68 | $4,180,323,637.00 | Buy | 7 | 2018 |
#29 | LGN | United States | $41.70 | $2,361,064,000.00 | Strong Buy | 15 | 2025 |
#30 | SOUN | United States | $11.64 | $148,404,000.00 | Buy | 8 | N/A |
#31 | FDMT | United States | $10.86 | $120,000.00 | Strong Buy | 9 | 2020 |
#32 | RCUS | United States | $21.55 | $240,000,000.00 | Buy | 8 | 2018 |
#33 | AGIO | United States | $27.29 | $44,791,000.00 | Buy | 9 | 2013 |
#34 | XOMA | United States | $25.14 | $47,106,000.00 | Strong Buy | 4 | N/A |
#35 | ADPT | United States | $15.43 | $252,754,000.00 | Strong Buy | 10 | 2019 |
#36 | ENOV | United States | $26.39 | $2,233,266,000.00 | Strong Buy | 6 | 2008 |
#37 | BEPC | United States | $38.76 | $3,828,000,000.00 | Buy | 4 | N/A |
#38 | VCYT | United States | $42.88 | $495,141,000.00 | Strong Buy | 8 | 2013 |
#39 | PHR | United States | $16.25 | $463,205,000.00 | Strong Buy | 17 | 2019 |
#40 | ONEW | United States | $11.55 | $1,872,334,000.00 | Buy | 6 | 2020 |
#41 | TAC | Canada | $13.86 | $1,783,342,546.00 | Strong Buy | 4 | N/A |
#42 | VIAV | United States | $18.04 | $1,145,200,000.00 | Buy | 8 | 1993 |
#43 | DYN | United States | $19.21 | $0.00 | Strong Buy | 16 | 2020 |
#44 | METC | United States | $15.59 | $579,503,000.00 | Buy | 8 | 2017 |
#45 | XPEV | China | $18.96 | $9,912,782,208.00 | Buy | 6 | 2020 |
#46 | CNTA | United Kingdom | $26.52 | $15,000,000.00 | Strong Buy | 11 | 2021 |
#47 | BEP | Canada | $27.91 | $6,300,000,000.00 | Buy | 10 | N/A |
#48 | PHAT | United States | $14.53 | $147,190,000.00 | Strong Buy | 6 | 2019 |
#49 | PTRN | United States | $12.63 | $2,293,676,000.00 | Strong Buy | 10 | 2025 |
#50 | HTFL | United States | $26.57 | $161,881,000.00 | Strong Buy | 4 | 2025 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $50 to Buy (December 13, 2025) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.